Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843869 · ClinicalTrials.gov registry record
Reversal of Tobacco-Related Sinusitis
A clinical trial of Rhinosinusitis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 282
- Enrollment target
- 1
- Study location
NCT00843869: Completed study of Rhinosinusitis, sponsored by University of Alabama at Birmingham.
NCT00843869 is a study of Rhinosinusitis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 282 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00843869, a study of Rhinosinusitis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 282 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is focused on identifying the prevalence of passive or active smoke exposure and zinc deficiency in a cohort of patients who meet the objective and subjective guidelines for chronic rhinosinusitis set forth by the Sinus and Allergy Health Partnership.
Primary Outcome
This study is focused on identifying the prevalence of passive or active smoke exposure and zinc deficiency in a cohort of patients who meet the objective and subjective guidelines for chronic rhinosinusitis set forth by the Sinus and Allergy Health Partnership.
Conditions Studied
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2008-08 |
| Est. Completion | 2015-02 |
What the finished NCT00843869 record still lists
NCT00843869 is an observational study that tracks outcomes without assigning an intervention. The registered 282 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Rhinosinusitis appearing as the primary indexed condition, and to 0 interventions.
NCT00843869 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT00843869 about?
NCT00843869 is a clinical study titled "Reversal of Tobacco-Related Sinusitis". This study is focused on identifying the prevalence of passive or active smoke exposure and zinc deficiency in a cohort of patients who meet the objective and subjective guidelines for chronic rhinosinusitis set forth by the Sinus and Allergy Health Partnership.
What is the current status of trial NCT00843869?
This trial is currently completed. The enrollment target is 282 participants. The study started on 2008-08. Estimated completion is 2015-02.
What conditions does trial NCT00843869 study?
This clinical trial studies the following conditions: Rhinosinusitis.
Who is sponsoring clinical trial NCT00843869?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00843869 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhinosinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02860364 · 282 participants · NA
Comparing Hypothermic Temperatures During Hemiarch Surgery
- NCT04867395 · 282 participants · NA
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
- NCT05101070 · 282 participants · Phase 1
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
- NCT06276491 · 282 participants · Phase 1
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia